Effect of drug treatment options on the mobility and expression of blaKPC.
暂无分享,去创建一个
[1] L. Rice,et al. The KQ Element, a Complex Genetic Region Conferring Transferable Resistance to Carbapenems, Aminoglycosides, and Fluoroquinolones in Klebsiella pneumoniae , 2008, Antimicrobial Agents and Chemotherapy.
[2] M. Synnestvedt,et al. Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae , 2009, Infection Control & Hospital Epidemiology.
[3] N. Hanson,et al. Point mutations in the inc antisense RNA gene are associated with increased plasmid copy number, expression of blaCMY-2 and resistance to piperacillin/tazobactam in Escherichia coli. , 2012, The Journal of antimicrobial chemotherapy.
[4] L. Danziger,et al. Steady-State Plasma and Bronchopulmonary Concentrations of Intravenous Levofloxacin and Azithromycin in Healthy Adults , 2003, Antimicrobial Agents and Chemotherapy.
[5] F. Champlin,et al. Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa. , 1989, Journal of medical microbiology.
[6] N. Hanson,et al. Model System To Evaluate the Effect of ampD Mutations on AmpC-Mediated β-Lactam Resistance , 2006, Antimicrobial Agents and Chemotherapy.
[7] D. Bonner,et al. Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus , 1993, Antimicrobial Agents and Chemotherapy.
[8] D. Paterson. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] R. Goering,et al. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. , 2003, The Journal of antimicrobial chemotherapy.
[10] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[11] G. Bierbaum,et al. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus. , 2011, International journal of medical microbiology : IJMM.
[12] Vincent H Tam,et al. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. , 2010, The Journal of antimicrobial chemotherapy.
[13] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[14] Baha Abdalhamid,et al. Escherichia coli: development of carbapenem resistance during therapy. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] D. Paterson,et al. Antibiotic resistance—What’s dosing got to do with it? , 2008, Critical care medicine.
[16] N. Hanson,et al. blaKPC RNA Expression Correlates with Two Transcriptional Start Sites but Not Always with Gene Copy Number in Four Genera of Gram-Negative Pathogens , 2011, Antimicrobial Agents and Chemotherapy.
[17] D. Clewell,et al. Properties of erythromycin-inducible transposon Tn917 in Streptococcus faecalis , 1980, Journal of bacteriology.
[18] R. Bonomo,et al. Outcomes and Genetic Relatedness of Carbapenem-Resistant Enterobacteriaceae at Detroit Medical Center , 2011, Infection Control & Hospital Epidemiology.
[19] Robert A. Bonomo,et al. Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae , 2010, Antimicrobial Agents and Chemotherapy.
[20] P. Coudron,et al. Plasmid-Mediated Resistance to Expanded-Spectrum Cephalosporins among Enterobacter aerogenesStrains , 1998, Antimicrobial Agents and Chemotherapy.
[21] M. Ferraro,et al. Plasmid-Mediated Carbapenem-Hydrolyzing Enzyme KPC-2 in an Enterobacter sp , 2004, Antimicrobial Agents and Chemotherapy.
[22] J. Collins,et al. A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics , 2007, Cell.
[23] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[24] P. Nordmann,et al. Functional Characterization of Tn4401, a Tn3-Based Transposon Involved in blaKPC Gene Mobilization , 2011, Antimicrobial Agents and Chemotherapy.
[25] S. Pournaras,et al. Characteristics of Meropenem Heteroresistance in Klebsiella pneumoniae Carbapenemase (KPC)-Producing Clinical Isolates of K. pneumoniae , 2010, Journal of Clinical Microbiology.
[26] Y. Carmeli,et al. Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in Israel , 2006, Antimicrobial Agents and Chemotherapy.
[27] N. Woodford,et al. Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4 , 2008, Antimicrobial Agents and Chemotherapy.
[28] G. Daikos,et al. Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions , 2012, Clinical Microbiology Reviews.